Parkinson Disease-Modification Encompassing Rotenone and 6-Hydroxydopamine Neurotoxicity by the Microtubule-Protecting Drug Candidate SKIP Yanina Ivashko-PachimaKim B. SeroogyIllana Gozes EditorialNotes 21 July 2021 Pages: 1515 - 1524
PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy Agata Grazia D’AmicoGrazia MaugeriVelia D’Agata ReviewPaper 05 January 2021 Pages: 1525 - 1535
PAC1 Receptor Internalization and Endosomal MEK/ERK Activation Is Essential for PACAP-Mediated Neuronal Excitability Victor MayGregory C. JohnsonRodney L. Parsons ReviewPaper 06 March 2021 Pages: 1536 - 1542
Lack of Pituitary Adenylate Cyclase–Activating Polypeptide (PACAP) Disturbs Callus Formation Gergő JózsaBalázs Dániel FülöpTamás Juhász OriginalPaper Open access 05 December 2019 Pages: 1543 - 1555
Changes in the Neurochemical Characterization of Enteric Neurons in the Porcine Duodenum After Administration of Low-Dose Salmonella Enteritidis Lipopolysaccharides Liliana RytelJoanna WojtkiewiczAnita Mikołajczyk OriginalPaper 14 January 2020 Pages: 1556 - 1566
Stability Test of PACAP in Eye Drops Anita K. KovacsTamas AtlaszGabor K. Toth OriginalPaper Open access 22 April 2020 Pages: 1567 - 1574
Intrabladder PAC1 Receptor Antagonist, PACAP(6-38), Reduces Urinary Bladder Frequency and Pelvic Sensitivity in Mice Exposed to Repeated Variate Stress (RVS) Beatrice M. GirardSusan E. CampbellMargaret A. Vizzard OriginalPaper 01 July 2020 Pages: 1575 - 1588
The G Protein–Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3 Terry W. MoodyLingaku LeeRobert T. Jensen OriginalPaper 22 September 2020 Pages: 1589 - 1597
Molecular Characteristics of Thalamic Gliomas in Adults Tianwei WangXiaodong NiuQing Mao OriginalPaper 01 February 2021 Pages: 1598 - 1604
UBE2R2-AS1 Inhibits Xenograft Growth in Nude Mice and Correlates with a Positive Prognosis in Glioma Wu XuDan-dan CheYa-wen Pan OriginalPaper 02 February 2021 Pages: 1605 - 1613
Overexpression of Cell-Surface Marker SLC16A1 Shortened Survival in Human High-Grade Gliomas Hong-Han LinWen-Chiuan TsaiKuang-Chen Hung OriginalPaper 27 February 2021 Pages: 1614 - 1621
Integrated Gene Expression and Methylation Analyses Identify DLL3 as a Biomarker for Prognosis of Malignant Glioma Aierpati MaimaitiXixian WangMaimaitijiang Kasimu OriginalPaper 13 March 2021 Pages: 1622 - 1635
Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K/AKT Signaling Pathway Qingping ZhangBinchu XuYou Zuo OriginalPaper Open access 19 April 2021 Pages: 1636 - 1647
In vivo Engineering of Chromosome 19 q-arm by Employing the CRISPR/AsCpf1 and ddAsCpf1 Systems in Human Malignant Gliomas (Hypothesis) Atefe AbakHamed ShooreiSoudeh Ghafouri-Fard OriginalPaper 15 May 2021 Pages: 1648 - 1663
An E3 Ubiquitin Ligase RNF139 Serves as a Tumor-Suppressor in Glioma Xiaofeng ChenWeiping KuangShucheng Zou OriginalPaper Open access 09 June 2021 Pages: 1664 - 1673
Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Rac Exchanger 2 Protein Facilitates Glioma Progression via Akt and Stat3 Signaling Jinxing ShangYabin LiQingling Bai OriginalPaper 28 July 2021 Pages: 1674 - 1682
CircPITX1 Regulates Proliferation, Angiogenesis, Migration, Invasion, and Cell Cycle of Human Glioblastoma Cells by Targeting miR-584-5p/KPNB1 Axis Yiqiang CaoFei WangJiang Long OriginalPaper 24 March 2021 Pages: 1683 - 1695
WDR81 Gene Silencing Can Reduce Exosome Levels in Human U87-MG Glioblastoma Cells Amin Tadayoni niaZahra BaziMorteza Oladnabi OriginalPaper 06 May 2021 Pages: 1696 - 1702
2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis Dezheng GaoAlphonce M. K. NyalaliFeng Li OriginalPaper 05 January 2021 Pages: 1703 - 1713
Analysis of the P53N a Novel Protein Encoded on Chromosome 22q12.1-12.3 in Glioblastomas and Ependymomas Specimens Bruce M. FrankelDavid CachiaArabinda Das OriginalPaper 17 February 2021 Pages: 1714 - 1722
